Andrés Avelino Trabanco-Suarez

Title: **Andrés Avelino Trabanco-Suarez: Innovator in Alzheimer's Disease Treatment**

Introduction

Andrés Avelino Trabanco-Suarez is a notable inventor located in Toledo, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Alzheimer's disease. Through his innovative approach, he has developed a unique compound that may offer new therapeutic options for this challenging condition.

Latest Patents

Trabanco-Suarez holds a patent for "Substituted pyrido[1,2-a]pyrazines and substituted pyrido[1,2-a][1,4]diazepines for the treatment of (inter alia) Alzheimer's disease." This invention revolves around novel substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-dione derivatives, which serve as gamma secretase modulators. The patent includes processes for preparing these compounds, pharmaceutical compositions that incorporate them, and the potential use of these compounds as medicaments.

Career Highlights

Throughout his career, Andrés Avelino Trabanco-Suarez has worked with reputable companies such as Janssen Pharmaceuticals, Inc. and Cellzome Limited. His roles in these organizations have enabled him to collaborate on advanced research and development projects, further honing his skills as an inventor in the pharmaceutical industry.

Collaborations

Trabanco-Suarez has collaborated with distinguished professionals in the field, including Frederik Jan Rita Rombouts and Henricus Jacobus Maria Gijsen. Their combined expertise has likely enriched the quality and impact of the innovative solutions they have worked on together.

Conclusion

Andrés Avelino Trabanco-Suarez exemplifies the spirit of innovation in pharmaceutical research, particularly in addressing the challenges posed by Alzheimer's disease. His patent signifies a promising advancement in treatment options, underscoring the importance of interdisciplinary collaboration and dedicated research in the pursuit of effective medical solutions.